0 Bewertungen

ID

12471

Beschreibung

The purpose of the study is to assess the efficacy (prevention of vascular events) and safety (especially bleedings) of Ticagrelor (AZD6140) compared with Clopidogrel, both given on top of low dose aspirin, in Asian/Japanese patients with acute coronary syndrome and a planned percutaneous coronary intervention (PCI). https://clinicaltrials.gov/ct2/show/NCT01294462

Link

https://clinicaltrials.gov/ct2/show/NCT01294462

Stichworte

  1. 28.07.15 28.07.15 -
  2. 21.11.15 21.11.15 -
Hochgeladen am

21. November 2015

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0

Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Itemgroup Kommentare für :

Item Kommentare für :


    Keine Kommentare

    Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

    Eligibility Ticagrelor Versus Clopidogrel Acute Coronary Syndrome NCT01294462

    Eligibility criteria

    1. StudyEvent: ODM
      1. Eligibility criteria
    Inclusion Criteria
    Beschreibung

    Inclusion Criteria

    Provision of signed informed consent
    Beschreibung

    Provision of signed informed consent

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0021430
    Index event of ST segment elevation ACS
    Beschreibung

    Index event of non-ST or ST segment elevation ACS

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C1536220
    Index event of non-ST segment elevation ACS
    Beschreibung

    Index event of non-ST segment elevation ACS

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C3537184
    Exclusion criteria
    Beschreibung

    Exclusion criteria

    Index event is an acute complication of percutaneous coronary intervention
    Beschreibung

    Index event is an acute complication of percutaneous coronary intervention

    Datentyp

    boolean

    Alias
    UMLS CUI [1,1]
    C0009566
    UMLS CUI [1,2]
    C1532338
    Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
    Beschreibung

    Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C1532338
    Oral anticoagulation therapy that cannot be stopped
    Beschreibung

    Oral anticoagulation therapy that cannot be stopped

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0003281
    The conditions associated with increased risk of bradycardiac events
    Beschreibung

    The conditions associated with increased risk of bradycardiac events

    Datentyp

    boolean

    Alias
    UMLS CUI-1
    C0428977

    Ähnliche Modelle

    Eligibility criteria

    1. StudyEvent: ODM
      1. Eligibility criteria
    Name
    Typ
    Description | Question | Decode (Coded Value)
    Datentyp
    Alias
    Item Group
    Inclusion Criteria
    Informed consent
    Item
    Provision of signed informed consent
    boolean
    C0021430 (UMLS CUI-1)
    STEMI
    Item
    Index event of ST segment elevation ACS
    boolean
    C1536220 (UMLS CUI-1)
    NSTEMI
    Item
    Index event of non-ST segment elevation ACS
    boolean
    C3537184 (UMLS CUI-1)
    Item Group
    Exclusion criteria
    PCI complication
    Item
    Index event is an acute complication of percutaneous coronary intervention
    boolean
    C0009566 (UMLS CUI [1,1])
    C1532338 (UMLS CUI [1,2])
    PCI
    Item
    Patient has undergone Percutaneous Coronary Intervention (PCI) after the index event before the first dose of study treatment
    boolean
    C1532338 (UMLS CUI-1)
    anticoagulation therapy
    Item
    Oral anticoagulation therapy that cannot be stopped
    boolean
    C0003281 (UMLS CUI-1)
    Bradycardia
    Item
    The conditions associated with increased risk of bradycardiac events
    boolean
    C0428977 (UMLS CUI-1)

    Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

    Zum Video